Data from: Delays and loss to follow up before treatment of drug-resistant TB following implementation of Xpert MTB/RIF in South Africa: a retrospective cohort study

  • Helen Cox (Creator)
  • Lindy Dickson-Hall (Creator)
  • Norbert Ndjeka (Creator)
  • Anja van’t Hoog (Amsterdam Institute for Global Health and Development, University of Amsterdam) (Contributor)
  • Alison Grant (Creator)
  • Franciscus Cobelens (Creator)
  • Wendy Stevens (Creator)
  • Mark Nicol (Creator)

Dataset

Description

Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,734 patients diagnosed in 2014. The number of diagnosed patients has increased substantially with the introduction of the Xpert MTB/RIF test, used for TB d...
Date made available20 Jan 2018
PublisherDryad

Access Dataset

Cite this